Internal Medicine, Medical Oncology · Nashville, TN
NPI
1194751354
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2004 Hayes St Ste 350
Nashville, TN, 37203
Phone (615) 312-3333
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
84,010 services
Medicare patients, 2024
456
Average age 73
Drug cost, 2024
$4.6M
1,425 prescriptions
Company payments, 2025
$1,288
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nancy W Peacock was code J0897 (injection, denosumab, 1 mg), 3,962 times for 37 patients. In total Nancy W Peacock billed 84,010 services in 167 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,962 | 37 | $20.36 | $81K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,072 | 45 | $0.09 | $185 |
| 85025 Blood Count | Office | 1,108 | 364 | $7.56 | $8,374 |
| 36415 Venipuncture Blood Collection | Office | 1,016 | 358 | $8.63 | $8,765 |
| 80053 Clinical Chemistry | Office | 963 | 355 | $10.27 | $9,888 |
| 99214 Office E&M - Established | Office | 488 | 257 | $80.70 | $39K |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 315 | 51 | $70.09 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 279 | 197 | $11.78 | $3,286 |
| 99215 Office E&M - Established | Office | 266 | 138 | $121.82 | $32K |
| 96367 Intravenous Infusion, Hydration | Office | 250 | 44 | $19.34 | $4,834 |
| 96413 Chemotherapy Administration | Office | 231 | 55 | $87.03 | $20K |
| 82784 Immunoassay | Office | 203 | 27 | $9.11 | $1,850 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 199 | 24 | $4.79 | $954 |
| 96375 Injection Administration | Office | 140 | 30 | $10.68 | $1,495 |
| 96372 Injection Administration | Office | 119 | 58 | $10.05 | $1,196 |
By year: 2022 $1.5M for 78,973 services; 2023 $1.6M for 90,909 services; 2024 $1.5M for 84,010 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,108 | 364 | $7.56 | $8,374 |
| 36415 Venipuncture Blood Collection | 1,016 | 358 | $8.63 | $8,765 |
| 80053 Clinical Chemistry | 963 | 355 | $10.27 | $9,888 |
| 82784 Immunoassay | 203 | 27 | $9.11 | $1,850 |
| 83521 Immunoassay | 105 | 19 | $16.92 | $1,777 |
| 83615 Clinical Chemistry | 100 | 52 | $5.92 | $592 |
| 82728 Clinical Chemistry | 87 | 53 | $13.29 | $1,156 |
| 83540 Clinical Chemistry | 77 | 45 | $6.30 | $485 |
| 84165 Clinical Chemistry | 72 | 36 | $10.53 | $758 |
| 83550 Clinical Chemistry | 72 | 43 | $8.51 | $613 |
Medicare prescription drug claims, 2024
In 2024, the drug Nancy W Peacock prescribed most often to Medicare patients was Anastrozole, with 233 prescriptions and refills. In total Nancy W Peacock wrote 1,425 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 233 | 622 | 73 | $4,637 |
| Letrozole Generic | 119 | 331 | 39 | $2,683 |
| Alendronate Sodium Generic | 101 | 276 | 31 | $777 |
| Ibrance Palbociclib | 66 | 66 | Under 11 | $1.0M |
| Prochlorperazine Maleate Generic | 65 | 69 | 26 | $816 |
| Tamoxifen Citrate Generic | 55 | 135 | 17 | $1,117 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 48 | 80 | Under 11 | $475 |
| Revlimid Lenalidomide | 43 | 43 | Under 11 | $678K |
| Dexamethasone Generic | 39 | 39 | 13 | $467 |
| Pantoprazole Sodium Generic | 37 | 73 | 12 | $373 |
| Ondansetron Odt Ondansetron | 35 | 35 | 15 | $576 |
| Acyclovir Generic | 33 | 59 | Under 11 | $436 |
| Potassium Chloride Generic | 28 | 44 | Under 11 | $263 |
| Exemestane Generic | 25 | 39 | Under 11 | $2,545 |
| Tasigna Nilotinib Hcl | 24 | 26 | Under 11 | $263K |
Brand drugs: - claims; generic drugs: 1,065 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nancy W Peacock $1,288 ($670 in general payments such as food, travel and fees and $618 for research) from 10 companies. The largest payer was Novartis Pharmaceuticals Corporation with $869.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 12 | $869 |
| Merck Sharp & Dohme LLC MRK | 5 | $149 |
| Daiichi Sankyo Inc. 4568.T | 3 | $75.03 |
| Abbvie Inc. ABBV | 2 | $47.01 |
| Eisai Inc. 4523.T | 1 | $29.39 |
| GlaxoSmithKline, LLC. GSK | 1 | $27.94 |
| Celgene Corporation BMY | 1 | $25.71 |
| Genentech USA, Inc. ROG.SW | 1 | $24.56 |
| Pfizer Inc. PFE | 1 | $23.11 |
| Accord Healthcare, Inc. | 1 | $16.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.